IR
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Disclosure
Total of 10posts
| Number | Title | Person with Duty to Submit | Receipt Date |
|---|---|---|---|
| 10 | [Revised]Lawsuit Filing, etc.(신주발행금지가처분) | 2026-11-04 | |
| 9 | [Revised]Filing or Application of Lawsuit, etc. (the Corporate Control Contest)(신주발행금지가처분) | 2026-11-04 | |
| 8 | [Revised]Contract of Shares Acquisition and Assignment concerning the Change of Control | 2026-11-04 | |
| 7 | [Revised]Decision on Paid-in Capital Increase(제3자배정) | 2026-11-04 | |
| 6 | [Revised]Resolutions for Convocation of General Meeting of Shareholders(임시주주총회) | 2026-11-04 | |
| 5 | Decision on Increase in Short-term Borrowing | 2026-11-02 | |
| 4 | Decision on Provision of Collateral for Others | 2026-11-02 | |
| 3 | [Revised]Decision on Paid-in Capital Increase(제3자배정-소액공모) | 2026-10-29 | |
| 2 | [Revised]Results of issuance(Voluntary Disclosure) | 2026-10-29 | |
| 1 | Filing or Application of Lawsuit, etc. (the Corporate Control Contest)(신주발행금지가처분) | 2026-10-28 |
